Cited by 101Hepatitis B Virus StudiesHepatitis C virus researchIntramuscular injections and effects

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

A longitudinal hepatitis B vaccine cohort demonstrates long-lasting hepatitis B virus (HBV) cellular immunity despite loss of antibody against HBV surface antigen.

Open access

Simons, Brenna C., Spradling, Philip R., Bruden, Dana J. T., Zanis, Carolyn, Case, Samantha, Choromanski, Tammy L., Apodaca, Minjun, Brogdon, Hazel D., Dwyer, Gaelen, Snowball, Mary, Negus, Susan, Bruce, Michael G., Morishima, Chihiro, Knall, Cindy, McMahon, Brian J.·2016·Journal of Infectious Diseases

DOI 10.1093/infdis/jiw142PMC PMC4918827

Open this paper in CoChat — free account

Abstract

BACKGROUND: Long-lasting protection resulting from hepatitis B vaccine, despite loss of antibody against hepatitis B virus (HBV) surface antigen (anti-HBs), is undetermined. METHODS: We recruited persons from a cohort vaccinated with plasma-derived hepatitis B vaccine in 1981 who have been followed periodically since. We performed serological testing for anti-HBs and microRNA-155 and assessed HBV-specific T-cell responses by enzyme-linked immunospot and cytometric bead array. Study subgroups were defined 32 years after vaccination as having an anti-HBs level of either ≥10 mIU/mL (group 1; n = 13) or <10 mIU/mL (group 2; n = 31). RESULTS: All 44 participants, regardless of anti-HBs level, tested positive for tumor necrosis factor α, interleukin 10, or interleukin 6 production by HBV surface antigen-specific T cells. The frequency of natural killer T cells correlated with the level of anti-HBs (P = .008). The proportion of participants who demonstrated T-cell responses to HBV core antigen varied among the cytokines measured, suggesting some natural exposure to HBV in the study group. No participant had evidence of breakthrough HBV infection. CONCLUSIONS: Evidence of long-lasting cellular immunity, regardless of anti-HBs level, suggests that protection afforded by primary immunization with plasma-derived hepatitis B vaccine during childhood and adulthood lasts at least 32 years.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/infdis/jiw142

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Biology of NKT Cells
Bendelac, A. S., Savage, P. B., & Teyton, L. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141711 · Cited by 2,169
MicroRNA profiling: approaches and considerations
Pritchard, C. C., Cheng, H. H., & Tewari, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3198 · Cited by 1,765
The evolution of gene regulation by transcription factors and microRNAs
Chen, K., & Rajewsky, N. (2007) · Nature Reviews Genetics · doi:10.1038/nrg1990 · Cited by 1,547
Hepatitis B Vaccine
Szmuness, W., Stevens, C. E., Harley, E. J., Zang, E. A., Oleszko, W. R., William, D. C., D, R. S. M., Morrison, J. M., & Kellner, A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010093031501 · Cited by 1,117
PREVENTION OF PERINATALLY TRANSMITTED HEPATITIS B VIRUS INFECTIONS WITH HEPATITIS B IMMUNE GLOBULIN AND HEPATITIS B VACCINE
Beasley, R. P., LEE, G. C.-Y., Roan, C., Hwang, L., Lan, C., Huang, F.-Y., & Chen, C.-L. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90624-4 · Cited by 815
Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual Men
Hadler, S. C., Francis, D. P., Maynard, J. E., Thompson, S. E., Judson, F. N., Echenberg, D. F., Ostrow, D. G., OʼMalley, P. M., Penley, K. A., Altman, N. L., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607243150401 · Cited by 608
MATERNAL DEATHS
Newcombe, R. G. (1975) · The Lancet · doi:10.1016/s0140-6736(75)90482-1 · Cited by 546
microRNAs and the immune response
Lindsay, M. A. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.04.004 · Cited by 475
Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose.
Bruce, M. G., Bruden, D., Hurlburt, D., Zanis, C., Thompson, G., Rea, L., Toomey, M., Townshend-Bulson, L., Rudolph, K., Bulkow, L., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv748 · Cited by 322
Antibody Levels and Protection after Hepatitis B Vaccination: Results of a 15-Year Follow-up
McMahon, B. J., Bruden, D. L., Petersen, K. M., BULKOW, L. R., Parkinson, A. J., Nainan, O. V., Khristova, M. L., Zanis, C. L., Peters, H. V., & Margolis, H. S. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00008 · Cited by 315
Antibody Levels and Protection after Hepatitis B Vaccine: Results of a 22‐Year Follow‐Up Study and Response to a Booster Dose
McMahon, B. J., Dentinger, C., Bruden, D. J. T., Zanis, C. L., Peters, H. V., Hurlburt, D., BULKOW, L. R., Fiore, A. E., Bell, B. P., & Hennessy, T. W. (2009) · The Journal of Infectious Diseases · doi:10.1086/606119 · Cited by 246
Hepatitis B Virus Genotypes in Alaska Native People with Hepatocellular Carcinoma: Preponderance of Genotype F
Livingston, S., Simonetti, J., McMahon, B. J., BULKOW, L. R., Hurlburt, K. J., Homan, C., Snowball, M. M., Cagle, H. H., Williams, J. L., & Chulanov, V. (2006) · The Journal of Infectious Diseases · doi:10.1086/509894 · Cited by 240
Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination
Bauer, T., & Jilg, W. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.08.058 · Cited by 215
Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program.
McMahon, B. J., Bulkow, L. R., Singleton, R. J., Williams, J., Snowball, M., Homan, C., & Parkinson, A. J. (2011) · Hepatology · doi:10.1002/hep.24442 · Cited by 201
Humoral and Cellular Immune Responses to a Hepatitis B Vaccine Booster 15–18 Years after Neonatal Immunization
Lu, C., Ni, Y., Chiang, B., Chen, P., Chang, M., Chang, L., Su, I., Kuo, H., Huang, L., Chen, D., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/587695 · Cited by 197
Protection Provided by Hepatitis B Vaccine in a Yupik Eskimo Population--Results of a 10-Year Study
Wainwright, R. B., BULKOW, L. R., Parkinson, A. J., Zanis, C. L., & McMahon, B. J. (1997) · The Journal of Infectious Diseases · doi:10.1093/infdis/175.3.674 · Cited by 182
Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: A follow-up study at 15 years☆
Hammitt, L. L., Hennessy, T., Fiore, A. E., Zanis, C. L., Hummel, K. B., Dunaway, E., BULKOW, L. R., & MCMAHON, B. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.06.059 · Cited by 167
Elimination of New Chronic Hepatitis B Virus Infections: Results of the Alaska Immunization Program
Harpaz, R., McMahon, B. J., Margolis, H. S., Shapiro, C. N., Havron, D., Carpenter, G., BULKOW, L. R., & Wainwright, R. B. (2000) · The Journal of Infectious Diseases · doi:10.1086/315259 · Cited by 156
Duration of Immunogenicity and Efficacy of Hepatitis B Vaccine in a Yupik Eskimo Population
Wainwright, R. B. (1989) · JAMA · doi:10.1001/jama.1989.03420160094029 · Cited by 147
Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons
McMahon, B. J., Helminiak, C., Wainwright, R. B., BULKOW, L. R., Trimble, B. A., & Wainwright, K. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90073-k · Cited by 132
Duration of Hepatitis B Immunity in Low Risk Children Receiving Hepatitis B Vaccinations From Birth
Petersen, K. M., BULKOW, L. R., McMahon, B. J., Zanis, C. L., Getty, M., Peters, H. V., & Parkinson, A. J. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000130952.96259.fd · Cited by 129
Persistence of Antibody to Hepatitis B and Protection From Disease Among Alaska Natives Immunized at Birth
Dentinger, C., McMahon, B. J., Butler, J. C., Dunaway, C. E., Zanis, C. L., BULKOW, L. R., Bruden, D. L., Nainan, O. V., Khristova, M. L., Hennessy, T. W., et al. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000176617.63457.9f · Cited by 126
Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages
Petersen, N. J., Barrett, D. H., Bond, W. W., Berquist, K. R., Favero, M. S., Bender, T. R., & Maynard, J. E. (1976) · Applied and Environmental Microbiology · doi:10.1128/aem.32.4.572-574.1976 · Cited by 122
Differences in Response to a Hepatitis B Vaccine Booster Dose Among Alaskan Children and Adolescents Vaccinated During Infancy
Samandari, T., Fiore, A. E., Negus, S. E., Williams, J. L., Kuhnert, W. L., McMahon, B. J., & Bell, B. P. (2007) · PEDIATRICS · doi:10.1542/peds.2007-0131 · Cited by 109
Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand
Poovorawan, Y., Chongsrisawat, V., Theamboonlers, A., Bock, H. L., Leyssen, M., & Jacquet, J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.074 · Cited by 104
Long–Term Response to Hepatitis B Vaccination and Response to Booster in Children Born to Mothers With Hepatitis B E Antigen
Huang, L., Chiang, B., Lee, C., Lee, P., Chi, W., & Chang, M. (1999) · Hepatology · doi:10.1002/hep.510290349 · Cited by 104
Twelve–Year Follow–Up of A Prospective Randomized Trial of Hepatitis B Recombinant Dna Yeast Vaccine Versus Plasma–Derived Vaccine Without Booster Doses in Children
Yuen, M., Lim, W.-L., Cheng, C.-C., Lam, S.-K., & Lai, C. (1999) · Hepatology · doi:10.1002/hep.510290327 · Cited by 75
Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination
Zhu, C., Liu, P., Chen, T., Ni, Z., Lu, L., Huang, F., Lu, J., Sun, Z., & Qu, C. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.098 · Cited by 69
Detection Methods for Study of the Stability of Hepatitis B Antigen on Surfaces
Favero, M. S., Bond, W. W., Petersen, N. J., Berquist, K. R., & Maynard, J. E. (1974) · The Journal of Infectious Diseases · doi:10.1093/infdis/129.2.210 · Cited by 63
Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven-year results
Wainwright, R. B. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.8.1634 · Cited by 63
THE CONTROL OF HEPATITIS B VIRUS INFECTION WITH VACCINE IN YUPIK ESKIMOS
Heyward, W. L., Bender, T. R., McMahon, B. J., Hall, D. B., Francis, D. P., Lanier, A. P., Alward, W. L. M., AHTONE, J. L., Murphy, B. L., & Maynard, J. E. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114061 · Cited by 62
The Hepatitis B Vaccine Protects Re-Exposed Health Care Workers, But Does Not Provide Sterilizing Immunity
Werner, J. M., Abdalla, A., Gara, N., Ghany, M. G., & Rehermann, B. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.044 · Cited by 58
Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers
Williams, J. L., Christensen, C. J., McMahon, B. J., BULKOW, L. R., Cagle, H. H., Mayers, J. S., Zanis, C. L., Parkinson, A. J., & Margolis, H. S. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00112-8 · Cited by 50
Innate immune responses support adaptive immunity: NKT cells induce B cell activation
Galli, G., Nuti, S., Tavarini, S., Galli‐Stampino, L., de Lalla, C., Casorati, G., Dellabona, P., & Abrignani, S. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00200-7 · Cited by 49
Waning‐off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post‐implementation of Taiwan’s national hepatitis B vaccination programme
Su, F., Chen, J. ‐., Cheng, S., Sung, K. ‐., Jeng, J. ‐., & Chu, F. (2007) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2007.00890.x · Cited by 43
Long-Term Humoral and Cellular Immune Response to Hepatitis B Vaccine in High-Risk Children 18–20 Years After Neonatal Immunization
Chinchai, T., Chirathaworn, C., Praianantathavorn, K., Theamboonlers, A., Hutagalung, Y., L., B. P. H., Thantiworasit, P., & Poovorawan, Y. (2009) · Viral Immunology · doi:10.1089/vim.2008.0087 · Cited by 39
Cytokine and Chemokine Responses in the Acute Phase of Hepatitis B Virus Replication in Naive and Previously Vaccinated Blood and Plasma Donors
Keating, S. M., Heitman, J. D., Wu, S., Deng, X., Stramer, S. L., Kuhns, M. C., Mullen, C., Norris, P. J., & Busch, M. P. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit563 · Cited by 38
Despite Biased TRBV Gene Usage against a Dominant HLA B57-Restricted Epitope, TCR Diversity Can Provide Recognition of Circulating Epitope Variants
Simons, B. C., VanCompernolle, S. E., Smith, R. M., Wei, J., Barnett, L. D., Lorey, S. L., Meyer‐Olson, D., & Kalams, S. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.5137 · Cited by 37
Assessing completeness of perinatal hepatitis B virus infection reporting through comparison of immunization program and surveillance data--United States.
(2011) · PubMed · Cited by 36
Increases in Levels of Antibody to Hepatitis B Surface Antigen in an Immunized Population
BULKOW, L. R., Wainwright, R. B., BULKOW, L. R., Wainwright, R. B., McMahon, B. J., & Parkinson, A. J. (1998) · Clinical Infectious Diseases · doi:10.1086/513939 · Cited by 33
Efficacy of hepatitis B vaccine boosters among neonatally vaccinated university freshmen in Taiwan
Su, F., Chu, F., Bai, C.-H., Lin, Y., Hsueh, Y., Sung, F.-C., & Yeh, C. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.036 · Cited by 31
Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan
Su, F., Bai, C., Chu, F., Lin, Y., Su, C., & Yeh, C. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.031 · Cited by 31
Choriodecidual Group B Streptococcal Infection Induces miR-155-5p in the Fetal Lung in Macaca nemestrina
McAdams, R. M., Bierle, C. J., Boldenow, E., Weed, S. E., Tsai, J. M., Beyer, R. P., MacDonald, J. W., Bammler, T. K., Liggitt, H. D., Farin, F. M., et al. (2015) · Infection and Immunity · doi:10.1128/iai.00695-15 · Cited by 28
Long-term protection of neonatal hepatitis B vaccination in a 30-year cohort in Hong Kong
Lin, A. W.-C., & Wong, K.-H. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.021 · Cited by 28
Immunological Reactivity of Blood from Healthy Humans to the rAls3p‐N Vaccine Protein
Baquir, B., Lin, L., Ibrahim, A. S., Fu, Y., Avanesian, V., Tu, A. A., Edwards, J. E., & Spellberg, B. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/649901 · Cited by 22
Human Immune Responses to H. pylori HLA Class II Epitopes Identified by Immunoinformatic Methods
Zhang, S., Desrosiers, J., Aponte-Pieras, J. R., DaSilva, K., Fast, L. D., Terry, F. E., Martin, W. D., Groot, A. S. D., Moise, L., & Moss, S. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094974 · Cited by 20
An air sampling technique for hepatitis B surface antigen.
Petersen, N. J., Bond, W. W., Jh, M., Favero, M. S., & Raij, L. R. (1976) · PubMed · Cited by 19
Cellular immune responses in patients with hepatitis B surface antigen seroclearance induced by antiviral therapy
Liang, M.-F., Ma, S., Hu, X., Zhou, B., Zhang, J., Chen, J., Wang, Z., Sun, J., Zhu, X., Abbott, W. G. H., et al. (2011) · Virology Journal · doi:10.1186/1743-422x-8-69 · Cited by 18
Increased Serum MicroRNA-155 Level Associated with Nonresponsiveness to Hepatitis B Vaccine
Xiong, Y., Chen, S., Liu, L., Zhao, Y. D., Lin, W., & Ni, J. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00044-13 · Cited by 18
Vaccine induced protection against hepatitis B
Damme, P. V., & Banatvala, J. E. (2003) · BMJ · doi:10.1136/bmj.326.7380.105 · Cited by 6

Flagged first, then by citations

Research works printed but not linked: 2

10.1001/archinte.1991.00400080118023 · DOI
Werner, 2013, Innate and adaptive immune responses correlate to antibody recall responses to hepatitis B booster vaccineation, Hepatology, 58, 612A

Sorted by citations

Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices.
Schillie, S., Vellozzi, C., Reingold, A., Harris, A., Haber, P., Ward, J. W., & Nelson, N. P. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6701a1 · Cited by 815
Hepatitis B Vaccines
Pattyn, J., Hendrickx, G., Vorsters, A., & Damme, P. V. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa668 · Cited by 328
Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention
Abara, W. E., Qaseem, A., Schillie, S. F., McMahon, B. J., & Harris, A. M. (2017) · Annals of Internal Medicine · doi:10.7326/m17-1106 · Cited by 150
Mumps Outbreaks in Vaccinated Populations—Is It Time to Re-assess the Clinical Efficacy of Vaccines?
Connell, A. R., Connell, J., Leahy, T. R., & Hassan, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02089 · Cited by 73

See all 101

Authors: Simons, B. C., Spradling, P. R., Bruden, D. J. T., Zanis, C., Case, S., Choromanski, T. L., Apodaca, M., Brogdon, H. D., Dwyer, G., Snowball, M., Negus, S., Bruce, M. G., Morishima, C., Knall, C., & McMahon, B. J.
Affiliations: Centers for Disease Control and Prevention (US)
Alaska Native Tribal Health Consortium (US)
University of Washington (US)
University of Alaska Anchorage (US)
Corresponding author: Simons, Brenna C.
ORCID: Simons, Brenna C.
Spradling, Philip R.
Bruden, Dana J. T.
Case, Samantha
Dwyer, Gaelen
Bruce, Michael G.
Morishima, Chihiro
McMahon, Brian J.
Venue: Journal of Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2016-04-07
Volume: 214
Issue: 2
Pages: 273-280
ISSN: 0022-1899 (ISSN-L)
1537-6613
DOI: 10.1093/infdis/jiw142
PMC: PMC4918827
OpenAlex: W2359724621
Cited by: 101
References: 50
Citations by year: 2026: 10 · 2025: 10 · 2024: 16 · 2023: 10 · 2022: 16 · 2021: 12 · 2020: 6 · 2019: 7 · 2018: 6 · 2017: 7 · 2016: 1
FWCI: 6.56
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: The Journal of Infectious Diseases (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
HighWire Press Open Archive (submittedVersion)
Funders: CDC (U01 PS001097)
National Institute of General Medical Sciences
National Institutes of Health
NIH (P20GM103395, U261IHS0046)
Topics: Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
Health Sciences › Medicine › Hepatology › Hepatitis C virus research
Health Sciences › Medicine › Emergency Medicine › Intramuscular injections and effects
Keywords: hepatitis B vaccine, hepatitis B virus, cell-mediated immunity, hepatitis B surface antigen, HBV core antigen, NKT cells, cytokine production, miR-155, plasma-derived vaccine
MeSH terms: Adult, Cytological Techniques, Female, Hepatitis B, Hepatitis B Antibodies, Hepatitis B Surface Antigens, Hepatitis B virus, Humans, Immunity, Cellular, Longitudinal Studies, Male, Middle Aged, T-Lymphocytes, Time Factors, Hepatitis B Vaccines, MicroRNAs, Enzyme-Linked Immunospot Assay

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A longitudinal hepatitis B vaccine cohort demonstrates long-lasting hepatitis B virus (HBV) cellular immunity despite loss of antibody against HBV surface antigen.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks